- Home
- DOCN vs ELAN Comparison
DOCN vs ELAN Comparison
Compare DOCN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCN | ELAN |
|---|---|---|
| Founded | 2011 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.2B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOCN | ELAN |
|---|---|---|
| Price | $93.28 | $22.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 17 |
| Target Price | ★ $176.20 | $31.07 |
| AVG Volume (30 Days) | 2.1M | ★ 4.6M |
| Earning Date | 11-03-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.15 | N/A |
| EPS | ★ 0.45 | 0.22 |
| Revenue | $901,427,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $30.79 | $8.77 |
| Revenue Next Year | $54.38 | $5.39 |
| P/E Ratio | $204.11 | ★ $103.18 |
| Revenue Growth | ★ 15.48 | 6.22 |
| 52 Week Low | $37.84 | $19.40 |
| 52 Week High | $187.50 | $27.98 |
Technical Indicators
Market Signals| Indicator | DOCN | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 47.38 |
| Support Level | $73.66 | $21.67 |
| Resistance Level | $94.24 | $23.34 |
| Average True Range (ATR) | 9.38 | 0.67 |
| MACD | -3.85 | 0.05 |
| Stochastic Oscillator | 8.78 | 31.99 |
Price Performance
Historical ComparisonAbout DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.